1. Ashmarin, I.P., Karazeeva, E.P., Lyapina, L.A., and Samonina, G.E., The simplest proline-containing peptides PG,GP,PGP,and GPGG: regulatory activity and possible sources of biosynthesis, Biochemistry (Moscow), 1998, vol. 63, no. 2, pp. 119–124.
2. Ashmarin, I.P., Kamenskii, A.A., Lyapina, L.A., Myasoedov, N.F., and Samonina, G.E., Gliprolins as independent regulators and stabilizers of other peptides, Vopr. Biol. Med. Farmatsevt. Khim., 2002, no. 1, pp. 24–27.
3. Beller, K.D., Mucodermal use of adapplicator: new pharmaceutical technologies, Biol. Meditsina, 2006, vol. 12, no. 2, pp. 15–18.
4. Grigor’eva, M.E., Lyapina, L.A., Shubina, T.A., Andreeva, L.A., Obergan, T.Yu., Pastorova, V.E., Myasoedov, N.F., and Ul’yanov, A.M., Protective effects of Pro–Gly–Pro–Arg under conditions of enhances blood clotting in experimental hyperglycemia, Tromboz, Gemostaz, Reologiya, 2011, no. 3(47), pp. 41–46.
5. Hasan, A.A.K., Warnock, M., Nieman, N., Srikanth, S., Mahdi, F., Krishnan, R., Tulinsky, A., and Schmaier, A.H., Mechanisms of Arg–Pro–Pro–Gly–Phe inhibition of thrombin, Am. J. Physiol. Heart Circ. Physiol., 2003, vol. 285, no. 1, pp. 183–193.